• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗心律失常药物监测的成本效益和成本节约分析。

Cost-benefit and cost-savings analyses of antiarrhythmic medication monitoring.

机构信息

The Ohio State University Wexner Medical Center, Ross Ambulatory Care Center, 452 West 10th Avenue, Columbus, OH 43210, USA.

出版信息

Am J Health Syst Pharm. 2012 Sep 15;69(18):1569-73. doi: 10.2146/ajhp110270.

DOI:10.2146/ajhp110270
PMID:22935939
Abstract

PURPOSE

The economic impact of pharmacist-managed antiarrhythmic drug therapy monitoring on an academic medical center's electrophysiology (EP) program was investigated.

METHODS

Data were collected for the initial two years of patient visits (n = 816) to a pharmacist-run clinic for antiarrhythmic drug therapy monitoring. A retrospective cost analysis was conducted to assess the direct costs associated with three appointment models: (1) a clinic office visit only, (2) a clinic visit involving electrocardiography and basic laboratory tests, and (3) a clinic visit including pulmonary function testing and chest x-rays in addition to electrocardiography and laboratory testing. A subset of patient cases (n = 18) were included in a crossover analysis comparing pharmacist clinic care and usual care in an EP physician clinic. The primary endpoints were the cost benefits and cost savings associated with pharmacy-clinic care versus usual care. A secondary endpoint was improvement of overall EP program efficiency.

RESULTS

The payer mix was 61.6% (n = 498) Medicare, 33.2% (n = 268) managed care, and 5.2% (n = 42) other. Positive contribution margins were demonstrated for all appointment models. The pharmacist-managed clinic also yielded cost savings by reducing overall patient care charges by 21% relative to usual care. By the second year, the pharmacy clinic improved EP program efficiency by scheduling an average of 24 patients per week, in effect freeing up one day per week of EP physician time to spend on other clinical activities.

CONCLUSION

Pharmacist monitoring of antiarrhythmic drug therapy in an out-patient clinic provided cost benefits, cost savings, and improved overall EP program efficiency.

摘要

目的

调查药剂师管理抗心律失常药物治疗监测对学术医疗中心电生理 (EP) 项目的经济影响。

方法

收集了 816 名患者在药剂师管理的抗心律失常药物治疗监测诊所就诊的前两年的数据。进行了回顾性成本分析,以评估三种预约模式(1. 仅诊所就诊;2. 诊所就诊包括心电图和基本实验室检查;3. 诊所就诊包括肺功能测试和胸部 X 光检查,以及心电图和实验室检查)相关的直接成本。对 18 例患者病例进行了交叉分析,比较了药剂师诊所护理和 EP 医生诊所的常规护理。主要终点是与常规护理相比,药房诊所护理的成本效益和成本节约。次要终点是提高 EP 项目整体效率。

结果

支付方构成比例为 61.6%(n=498)医疗保险、33.2%(n=268)管理式医疗和 5.2%(n=42)其他。所有预约模式均显示出正的边际贡献。与常规护理相比,药剂师管理的诊所还通过降低总患者护理费用 21% 实现了成本节约。到第二年,药房诊所通过平均每周安排 24 名患者,实际上每周为 EP 医生腾出一天时间用于其他临床活动,提高了 EP 项目的效率。

结论

在门诊诊所中,药剂师对抗心律失常药物治疗的监测带来了成本效益、成本节约,并提高了 EP 项目的整体效率。

相似文献

1
Cost-benefit and cost-savings analyses of antiarrhythmic medication monitoring.抗心律失常药物监测的成本效益和成本节约分析。
Am J Health Syst Pharm. 2012 Sep 15;69(18):1569-73. doi: 10.2146/ajhp110270.
2
Medication Therapy Management: 10 Years of Experience in a Large Integrated Health Care System.药物治疗管理:在大型综合性医疗保健系统中的 10 年经验。
J Manag Care Spec Pharm. 2020 Sep;26(9):1057-1066. doi: 10.18553/jmcp.2020.26.9.1057.
3
Evaluation of a pharmacist-managed amiodarone monitoring program.药师管理的胺碘酮监测项目评估
J Manag Care Pharm. 2011 Sep;17(7):513-22. doi: 10.18553/jmcp.2011.17.7.513.
4
Initial experience with antiarrhythmic medication monitoring by clinical pharmacists in an outpatient setting: a retrospective review.临床药师在门诊环境中进行抗心律失常药物监测的初步经验:一项回顾性研究。
Clin Ther. 2009 Jun;31(6):1209-18. doi: 10.1016/j.clinthera.2009.06.014.
5
Evaluation of a pharmacist-run antiarrhythmic clinic in an ambulatory practice.在门诊实践中对药剂师主导的抗心律失常诊所的评估。
J Am Pharm Assoc (2003). 2015 Sep-Oct;55(5):546-51. doi: 10.1331/JAPhA.2015.14260.
6
Clinical and Economic Benefits of Pharmacist Involvement in a Community Hospital-Affiliated Patient-Centered Medical Home.临床和经济效益的药剂师参与社区医院相关的以患者为中心的医疗之家。
J Manag Care Spec Pharm. 2018 Feb;24(2):160-164. doi: 10.18553/jmcp.2018.24.2.160.
7
Economic evaluations of pharmacist-managed services in people with diabetes mellitus: a systematic review.糖尿病患者中药剂师管理服务的经济学评估:一项系统综述。
Diabet Med. 2016 Apr;33(4):421-7. doi: 10.1111/dme.12976. Epub 2015 Oct 28.
8
Improving cost-effectiveness of and outcomes from drug therapy in patients with atrial fibrillation in managed care: role of the pharmacist.提高管理式医疗中房颤患者药物治疗的成本效益和治疗效果:药剂师的作用。
J Manag Care Pharm. 2009 Aug;15(6 Suppl B):S19-25. doi: 10.18553/jmcp.2009.15.s6-b.19.
9
Evaluation of a pharmacist-managed electrolyte protocol in outpatients on antiarrhythmic medications.评估药师管理的抗心律失常药物门诊患者电解质方案。
J Am Pharm Assoc (2003). 2017 Jul-Aug;57(4):526-531. doi: 10.1016/j.japh.2017.05.001. Epub 2017 Jun 10.
10
PharmacistCARE: description of a pharmacist care service and lessons learned along the way.药剂师关怀:一项药剂师关怀服务的描述及一路走来的经验教训。
J Am Pharm Assoc (2003). 2008 Nov-Dec;48(6):793-802. doi: 10.1331/JAPhA.2008.07132.

引用本文的文献

1
The cost-effectiveness of pharmacist-physician collaborative care models vs usual care on time in target systolic blood pressure range in patients with hypertension: a payer perspective.药师-医师协作护理模式与常规护理对高血压患者目标收缩压达标时间的成本效果分析:支付者视角。
J Manag Care Spec Pharm. 2021 Dec;27(12):1680-1690. doi: 10.18553/jmcp.2021.27.12.1680.
2
Clinical implications from the European Heart Rhythm Association consensus document on antiarrhythmic drug therapy.欧洲心律协会抗心律失常药物治疗共识文件的临床意义
Anatol J Cardiol. 2018 Jul;20(1):48-51. doi: 10.14744/AnatolJCardiol.2018.03285.
3
Pharmacist-managed clinics for patient education and counseling in Japan: current status and future perspectives.
日本由药剂师管理的患者教育与咨询诊所:现状与未来展望。
J Pharm Health Care Sci. 2015 Jan 28;1:2. doi: 10.1186/s40780-014-0001-4. eCollection 2015.